Guaifenesin Mega Study
Contents
Guaifenesin
Guaifenesin

Related

A
Tablets
A
Treatments
A
Effects
A
User Variables 2
A
Measurements 2

Tags

Guaifenesin

Treatment Effectiveness

User reported effectiveness ratings Guaifenesin for various conditions.

Conditions Major Improvement Moderate Improvement Much Worse No Effect Worse Responses
Neck Pain 17% 0% 8% 58% 17% 12
Chronic Sinusitis 4% 35% 4% 52% 4% 23
Fibromyalgia 5% 17% 7% 64% 7% 123
Throat Clearing 0% 27% 9% 64% 0% 11
Fatigue 10% 25% 8% 54% 3% 118

Side Effects

User-reported side effects of Guaifenesin

Side Effect Percent of Reports Guaifenesin
Allergic to Cymbalta 19%
Extreme Dizziness 67%
Shortness of Breath 25%
Vomiting 5%
Headache 14%
Nausea 17%

Below is the degree of change seen after Guaifenesin is higher than average.

Outcomes
of
Below is the change in the listed outcome after is higher than average.
Sort by Effect Size
Sort by Confidence
% Change from Baseline*
*
Change in the listed outcome after is higher than average.

Guaifenesin Info

Property Value
Variable Name Guaifenesin
Aggregation Method SUM
Analysis Performed At 2020-09-15
Duration of Action 21 days
Filling Value 0
Kurtosis 57.549590163934
Maximum Allowed Value 20 tablets
Mean 0.5083335 tablets
Median 0 tablets
Minimum Allowed Value 0 tablets
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 10
Number of Measurements 2
Number of Measurements (including those generated by tagged, joined, or child variables) 1
Public true
Onset Delay 30 minutes
Standard Deviation 0.12856816240324
Unit Tablets
User Variables 2
UPC 885132679252
Variable Category Treatments
Variable ID 1333
Variance 0.016530054644809